google-site-verification: google250b31d841cb28a3.html google-site-verification: google227f3e72c8574d44.html
top of page

Recharge
beachwood

HUMAN body charging station

alzheimer's therapy

alzheimers-disease-risk (002).jpg

alzheimer's disease OVERVIEW

Alzheimer's disease (AD) is the most common form of dementia among older people. Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities.  Alzheimer's Disease begins slowly. It first involves the parts of the brain that control thought, memory and language. People with Alzheimer's Disease may have trouble remembering things that happened recently or names of people they know. A related problem, mild cognitive impairment (MCI),

THERAPY OVERVIEW

Alzheimer's disease pathophysiology is the accumulation of hyperphosphorylated tau protein neurofibrillary tangles and subsequently amyloid-beta (Aβ) plaques. PBM and neurobiofeedback (NBF)address the multiple gene expression and upregulation of multiple pathogenic pathway inflammation, reactive oxidative stress, mitochondrial disorders, insulin resistance, methylation defects, regulation of neuroprotective factors, and regional hypoperfusion of the brain. PBM-treated subjects showed that active treatment subjects tended to show greater improvement in the functioning of the executive: clock drawing, immediate recall, practical memory, and visual attention and task switching (Trails A&B). A larger study using the CerebroLite helmet in Temple Texas again of subjects in a double-blind, placebo-controlled IRB-approved FDA Clinical Trial demonstrated gain in memory and cognition by increased clock drawing.

SCIENTIFIC BACKED RESULTS

Treatment of neurodegeneration: integrating Photobiomodulation and neurofeedback in Alzheimer's dementia and Parkinson's: a review
MH Berman, TW Nichols - Photobiomodulation, photomedicine, and …, 2019 - liebertpub.com

Photobiomodulation for Alzheimer's disease: has the light dawned?
MR Hamblin - Photonics, 2019 - mdpi.com

 Photobiomodulation with near infrared light helmet in a pilot, placebo controlled clinical trial in dementia patients testing memory and cognition
MH Berman, JP Halper, TW Nichols… - Journal of neurology …, 2017 - ncbi.nlm.nih.gov

Significant improvement in cognition in mild to moderately severe dementia cases treated with transcranial plus intranasal photobiomodulation: case series report
AE Saltmarche, MA Naeser, KF Ho… - … and laser surgery, 2017 - liebertpub.com

 

effectiveness

A recent demonstrated that after 12 weeks, there were improvements in ADAS-cog (group × time interaction: F1,6 = 16.35, p = 0.007) and NPI (group × time interaction: F1,6 = 7.52, p = 0.03), increased cerebral perfusion (group × time interaction: F1,6 = 8.46, p < 0.03), and increased connectivity between the posterior cingulate cortex and lateral parietal nodes within the default-mode network in the PBM group.

LL Chao - Photobiomodulation, photomedicine, and laser surgery, 2019 - liebertpub.com

HOW OFTEN

How often should you repeat this therapy? The Alzheimer's disease therapy program at Recharge requires a once per week visit to the club for 90 minutes per session.

 

RESULTS

What are the results of this therapy?  After approximately 6-8 weeks clients should see an improvement

 

Cost

 How much does this service cost?  The cost for this plan is $99 per month.  There are no contracts or long term commitments.  To get started you will need to purchase a Recharge Health Plan

 

 

bottom of page